The World Health Organization (WHO), along with its 194 Member States and other partners, will celebrate its 75th anniversary on April 7, 2023, by urging a renewed push for health equity.
Roche (6: RO, ROG; OTCQX: RHHBY) announced that it has entered into a collaboration with Eli Lilly and Company to support the development of Roche’s Elecsys® Amyloid Plasma Panel (EAPP).
WHO is pleased to report that three manufacturers have signed licensing agreements with the Medicines Patent Pool (MPP) to develop long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP).
The Bioprocessing Excellence in South Asia Award was given during the Asia-Pacific Bioprocessing Excellence Awards (ABEA) 2023, which took place in Singapore earlier this month. The award was given to Biocon Biologics Ltd (BBL), a division of Biocon Ltd.
To market a generic version of Ingrezza® Capsules, 40 mg, 60 mg, and 80 mg of Neurocrine Biosciences, Inc., Lupin Limited (Lupin) today announced that its Abbreviated New Drug Application (ANDA), Valbenazine Capsules, 40 mg, 60 mg, and 80 mg, has received provisional approval from the United States Food and Drug Administration (U.S. FDA).
The USFDA has granted Prior Approval Supplement (PAS) permission to Zydus Lifesciences Limited (previously Cadila Healthcare Ltd.) to commercialize Mycophenolate Mofetil Injection USP, 500 mg/vial (US RLD: CellCept injection).
Cyprium Therapeutics, Inc. (“Cyprium”), a Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) subsidiary, today announced positive data on CUTX-101, copper histidinate (CuHis), in patients with Menkes disease.
The leading pharmaceutical company in the world, Lupin Limited (Lupin), today reported that its alliance partner Caplin Steriles Limited (Caplin) has received final FDA approval for its Abbreviated New Drug Application (ANDA) for Thiamine Hydrochloride Injection USP.
The dermatology businesses of Dr. Reddy’s Laboratories Ltd. today announced the signing of a deal to divest certain non-core brands of the firm to Eris Lifesciences Limited.
To combat malaria, more than 2 billion Insecticide-Treated Nets have been supplied globally since 2005.
